CORBUS PHARMACEUTICALS HLDG
Reported by TIAA CREF INVESTMENT MANAGEMENT LLC
Reported 124,228 shares, up 8,572 (7.4%) from the prior quarter.
Reported value -7.7%; share count 7.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2017-06-30 | 760000 |
| 2017-09-30 | 825000 |
| 2017-12-31 | 821000 |
| 2018-03-31 | 758000 |
| 2018-06-30 | 534000 |
| 2018-09-30 | 751000 |
| 2018-12-31 | 581000 |
| 2019-03-31 | 692000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2019 | Unchanged | 99,525 | 0 (0.0%) | < 0.01% | $692,000 | 2019-05-14 | |
| Q4 2018 | Unchanged | 99,525 | 0 (0.0%) | < 0.01% | $581,000 | 2019-02-14 | |
| Q3 2018 | Reduced | 99,525 | -6,295 (-5.9%) | < 0.01% | $751,000 | 2018-11-14 | |
| Q2 2018 | Reduced | 105,820 | -18,408 (-14.8%) | < 0.01% | $534,000 | 2018-08-14 | |
| Q1 2018 | Added | 124,228 | +8,572 (7.4%) | < 0.01% | $758,000 | 2018-05-14 | |
| Q4 2017 | Added | 115,656 | +279 (0.2%) | < 0.01% | $821,000 | 2018-02-14 | |
| Q3 2017 | Reduced | 115,377 | -5,185 (-4.3%) | < 0.01% | $825,000 | 2017-11-13 | |
| Q2 2017 | New | 120,562 | +120,562 (0.0%) | < 0.01% | $760,000 | 2017-08-10 |
Who else reported the position
88 managers reported CORBUS PHARMACEUTICALS HLDG for Q1 2018.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 4,387,188 | +2,289,684 | < 0.01% | $26,762,000 | 6 qtrs |
| Knoll Capital Management LLC | Unchanged | 3,856,985 | 0 | 24.16% | $23,528,000 | 12 qtrs |
| BlackRock Inc | Added | 3,648,352 | +53,666 | < 0.01% | $22,256,000 | 5 qtrs |
| ETF MANAGERS GROUP LLC | Added | 2,456,921 | +2,229,245 | 0.88% | $14,496,000 | 2 qtrs |
| VANGUARD GROUP INC | Added | 2,161,309 | +19,156 | < 0.01% | $13,184,000 | 12 qtrs |
| IFP Advisors Inc | Unchanged | 1,000,805 | 0 | 0.32% | $7,106,000 | 9 qtrs |
| STATE STREET CORPORATION | Added | 797,146 | +94,278 | < 0.01% | $4,861,000 | 7 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 660,714 | 0 | 0.03% | $4,030,000 | 6 qtrs |
| MORGAN STANLEY | Added | 620,369 | +60,474 | < 0.01% | $3,784,000 | 12 qtrs |
| NORTHERN TRUST CORPORATION | Added | 531,969 | +7,815 | < 0.01% | $3,245,000 | 12 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2018
- Filed
- May 14, 2018
- Filing type
- 13F-HR
- Position type
- CS
Voting authority reported
- Sole
- 124,228
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.